会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • APPARATUS AND METHODS TO COMMUNICATIVELY COUPLE FIELD DEVICES TO CONTROLLERS IN A PROCESS CONTROL SYSTEM
    • 将过程控制系统中的联动现场设备与控制器通信的装置和方法
    • US20100077111A1
    • 2010-03-25
    • US12236165
    • 2008-09-23
    • David HolmesGary Keith Law
    • David HolmesGary Keith Law
    • G06F13/00
    • H04L12/40013G05B2219/25014G05B2219/25248H04L43/50H04L67/12H04L69/18H04L2012/40221H04L2012/40254
    • Example apparatus and methods to communicatively couple field devices to controllers in a process control system are disclosed. An example method of changing a communication protocol of a first field device in a process control system includes decoupling from the first field device a first removable communication module configured to communicate using a first communication protocol. The example method also includes coupling to the first field device a second removable communication module configured to communicate using a second communication protocol. After coupling the second removable communication module, the first field device is configured to communicate using the second communication protocol. In addition, the first field device is coupled to a first communication channel on an input/output card when communicating using the first communication protocol and the first field device is coupled to the first communication channel on the input/output card when communicating using the second communication protocol.
    • 公开了将现场设备通信耦合到过程控制系统中的控制器的示例性设备和方法。 改变过程控制系统中的第一现场设备的通信协议的示例性方法包括:从第一现场设备解耦配置为使用第一通信协议通信的第一可移动通信模块。 示例性方法还包括将第二可移动通信模块耦合到第一现场设备,第二可移动通信模块被配置为使用第二通信协议进行通信。 在耦合第二可移动通信模块之后,第一现场设备被配置为使用第二通信协议进行通信。 此外,当使用第一通信协议进行通信时,第一现场设备耦合到输入/输出卡上的第一通信信道,并且当使用第二通信协议进行通信时,第一现场设备耦合到输入/输出卡上的第一通信信道 通讯协议。
    • 2. 发明授权
    • Apparatus and methods to communicatively couple field devices to controllers in a process control system
    • 将现场设备通信耦合到过程控制系统中的控制器的装置和方法
    • US09083548B2
    • 2015-07-14
    • US12236165
    • 2008-09-23
    • David HolmesGary Keith Law
    • David HolmesGary Keith Law
    • H04L12/40H04L29/08H04L29/06H04L12/26
    • H04L12/40013G05B2219/25014G05B2219/25248H04L43/50H04L67/12H04L69/18H04L2012/40221H04L2012/40254
    • Example apparatus and methods to communicatively couple field devices to controllers in a process control system are disclosed. An example method of changing a communication protocol of a first field device in a process control system includes decoupling from the first field device a first removable communication module configured to communicate using a first communication protocol. The example method also includes coupling to the first field device a second removable communication module configured to communicate using a second communication protocol. After coupling the second removable communication module, the first field device is configured to communicate using the second communication protocol. In addition, the first field device is coupled to a first communication channel on an input/output card when communicating using the first communication protocol and the first field device is coupled to the first communication channel on the input/output card when communicating using the second communication protocol.
    • 公开了将现场设备通信耦合到过程控制系统中的控制器的示例性设备和方法。 改变过程控制系统中的第一现场设备的通信协议的示例性方法包括:从第一现场设备解耦配置为使用第一通信协议通信的第一可移动通信模块。 示例性方法还包括将第二可移动通信模块耦合到第一现场设备,第二可移动通信模块被配置为使用第二通信协议进行通信。 在耦合第二可移动通信模块之后,第一现场设备被配置为使用第二通信协议进行通信。 此外,当使用第一通信协议进行通信时,第一现场设备耦合到输入/输出卡上的第一通信信道,并且当使用第二通信协议进行通信时,第一现场设备耦合到输入/输出卡上的第一通信信道 通讯协议。
    • 6. 发明申请
    • COMBINATIONS COMPRISING DEPEPTIDYPEPTIDASE-IV INHIBITORS AND ANTIDIABETIC AGENTS
    • 包含抑肽酶IV抑制剂和抗生素的组合
    • US20080076811A1
    • 2008-03-27
    • US11868129
    • 2007-10-05
    • Bork BalkanThomas HughesDavid HolmesEdwin Villhauer
    • Bork BalkanThomas HughesDavid HolmesEdwin Villhauer
    • A61K31/427A61K31/40A61P3/04A61P3/10
    • A61K31/40A61K31/421A61K31/422A61K31/427A61K31/4439A61K45/06A61K2300/00
    • The invention relates to a combination which comprises a DPP-IV inhibitor and at least one further antidiabetic compound, preferably selected from the group consisting of insulin signalling pathway modulators, like inhibitors of protein tyrosine phosphatases (PTPases), non-small molecule mimetic compounds and inhibitors of glutamine-fructose-6-phosphate amidotransferase (GFAT), compounds influencing a dysregulated hepatic glucose production, like inhibitors of glucose-6-phosphatase (G6Pase), inhibitors of fructose-1,6-bisphosphatase (F-1,6-BPase), inhibitors of glycogen phosphorylase (GP), glucagon receptor antagonists and inhibitors of phosphoenolpyruvate carboxykinase (PEPCK), pyruvate dehydrogenase kinase (PDHK) inhibitors, insulin sensitivity enhancers, insulin secretion enhancers, α-glucosidase inhibitors, inhibitors of gastric emptying, insulin, and α2-adrenergic antagonists, for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of conditions mediated by dipeptidylpeptidase-IV (DPP-IV), in particular diabetes, more especially type 2 diabetes mellitus, conditions of impaired glucose tolerance (IGT), conditions of impaired fasting plasma glucose, metabolic acidosis, ketosis, arthritis, obesity and osteoporosis; and the use of such combination for the cosmetic treatment of a mammal in order to effect a cosmetically beneficial loss of body weight.
    • 本发明涉及包含DPP-IV抑制剂和至少一种另外的抗糖尿病化合物的组合,其优选选自胰岛素信号通路调节剂,如蛋白酪氨酸磷酸酶(PTPases)的抑制剂,非小分子模拟化合物和 谷氨酰胺 - 果糖-6-磷酸酰胺转移酶(GFAT)的抑制剂,影响失调的肝脏葡萄糖产生的化合物,如葡萄糖-6-磷酸酶(G6Pase)的抑制剂,果糖-1,6-二磷酸酶抑制剂(F-1,6- BPA),糖原磷酸化酶(GP)的抑制剂,胰高血糖素受体拮抗剂和磷酸烯醇丙酮酸羧激酶(PEPCK),丙酮酸脱氢酶激酶(PDHK)抑制剂,胰岛素敏感性增强剂,胰岛素分泌增强剂,α-葡糖苷酶抑制剂,胃排空抑制剂,胰岛素 和α2 - 肾上腺素能拮抗剂,用于同时,分开或顺序使用以预防,延迟进展o 治疗由二肽基肽酶-IV(DPP-IV)介导的病症,特别是糖尿病,特别是2型糖尿病,葡萄糖耐量降低的病症(IGT),空腹血浆葡萄糖受损的病症,代谢性酸中毒,酮症,关节炎,肥胖 和骨质疏松症; 以及使用这种组合来进行哺乳动物的美容治疗,以实现美容上有益​​的体重损失。